Research Article
Tocilizumab Effect on Lipid Profile in Correlation to Cardiovascular Events: A Retrospective Cohort Study
Table 3
Clinical characteristics at baseline: concomitant illness.
| | Tocilizumab () | Control () | Total () | value |
| Diabetes mellitus | 13 (18) | 17 (24) | 30 (21) | 0.44 | Hypertension | 15 (21) | 15 (21) | 30 (21) | 0.97 | Hyperlipidemia | 7 (10) | 6 (8) | 13 (9) | 0.75 | Liver diseases | 0 (0) | 2 (3) | 2 (1) | 0.16 | CKD | 1 (1) | 1 (1) | 2 (1) | 0.99 | Statin use | 19 (27) | 20 (28) | 39 (27) | 0.89 |
|
|